Document Detail


Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and D-norgestrel.
MedLine Citation:
PMID:  7238044     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Contraceptive vaginal rings (CVRs) impregnated with a combination of estradiol and d-norgestrel were studied in 39 women. The rings were inserted as three weeks "in" and one week "out" schedule to allow withdrawal bleeding. Ovulation was inhibited in all cycles and promptly resumed on completion of the treatment cycles. Bleeding control was excellent. Incidence of breakthrough bleeding was 2.11 per cent in 273 cycles studied, with 89 per cent of the cycles within the acceptable range (25 - 35 days). Levels of estradiol after an initial rise were maintained between 50-100 pg/ml and, d-norgestrel levels were relatively constant between 1.8-3 ng/ml during the period while the ring remained in situ. Clinical acceptance was good. The main problem encountered was of spontaneous expulsion of the ring in the toilet, which might be due to the squatting toilet habits of Indian women and laxity of vaginal wall.
Contraceptive vaginal rings (CVRs) impregnated with a combination of estradiol and d-norgestrel were studied in 39 women. The rings were inserted on a 3 weeks "in" and 1 week "out" schedule to allow withdrawal bleeding. Ovulation was inhibited in all cycles and promptly resumed on completion of the treatment cycles. Bleeding control was excellent. Incidence of breakthrough bleeding was 2.11% in 273 cycles studied, with 89% of the cycles within the acceptable range (25-35 days). Levels of estradiol after an initial rise were maintained between 50-100 pg/ml and, d-norgestrel levels were relatively constant between 1.83 ng/ml during the period while the ring remained in situ. Clinical acceptance was good. The main problem encountered was of spontaneous expulsion of the ring in the toilet, which might be due to the squatting toilet habits of Indian women and laxity of the vaginal wall.
Authors:
S Mehta; U M Joshi; G M Sankolli; A Adatia; U M Donde; B N Saxena
Related Documents :
8931634 - Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients wi...
17904804 - Incremental value of left ventricular diastolic function reserve index for predicting e...
16242194 - Adults with ebstein's anomaly--cardiopulmonary exercise testing and bnp levels exercise...
2524714 - Atrial natriuretic factor during the perinatal period: equal depletion in both atria.
21044724 - Characteristics of people with chronic lung disease who rest during the six-minute walk...
6666614 - Energy sources mobilization during muscular exercise in pregnant rats.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Contraception     Volume:  23     ISSN:  0010-7824     ISO Abbreviation:  Contraception     Publication Date:  1981 Mar 
Date Detail:
Created Date:  1981-08-20     Completed Date:  1981-08-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0234361     Medline TA:  Contraception     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  241-50     Citation Subset:  IM; J    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alkaline Phosphatase / blood
Aspartate Aminotransferases / blood
Body Weight
Contraceptive Devices, Female* / adverse effects
Estradiol / administration & dosage*,  blood
Female
Humans
Menstruation
Norgestrel / administration & dosage*,  blood
Chemical
Reg. No./Substance:
50-28-2/Estradiol; 6533-00-2/Norgestrel; EC 2.6.1.1/Aspartate Aminotransferases; EC 3.1.3.1/Alkaline Phosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fibrinolytic response and oral contraceptive associated thromboembolism.
Next Document:  Fluid-filled silastic capsules : a new approach to a more constant steroidal drug delivery system.